The Circadian Rhythm of Copeptin (Co-Rhythm)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02604875|
Recruitment Status : Completed
First Posted : November 16, 2015
Last Update Posted : August 15, 2016
|Condition or disease||Intervention/treatment|
|Circadian Rhythm Copeptin Blood Levels||Other: observation|
|Study Type :||Observational|
|Actual Enrollment :||18 participants|
|Official Title:||The Circadian Rhythm of Copeptin|
|Study Start Date :||November 2015|
|Actual Primary Completion Date :||April 2016|
|Actual Study Completion Date :||April 2016|
Blood samples will be taken for measuring copeptin levels in healthy subjects.
blood sampling during 24 hours
- measurement of copeptin values in mmol/l within 24 hours to assess the amount of release in a day curve. [ Time Frame: 24 hours ]The primary outcome measure is to compare the copeptin concentration in the early afternoon and the early morning by blood sampling at different time points. Evaluation of the question if there is a circadian rhythm in the copeptin release.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02604875
|University Hospital Basel|
|Basel, Basel-Stadt, Switzerland, 4031|
|Principal Investigator:||Mirjam Christ-Crain, MD, Prof.||University Hospital, Basel, Switzerland|